Skip to main content

John S. Healy

Equibles does not estimate personal net worth.

Get an email with a short summary when Contineum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CTNM alerts

About John S. Healy

John S. Healy is recorded as General Counsel at Contineum Therapeutics, Inc. (CTNM). The newest filing on record that lists John S. Healy as General Counsel at Contineum Therapeutics, Inc. (CTNM) is dated April 30, 2026. The proxy statement of Contineum Therapeutics, Inc. reports total compensation of $2,562,489 for John S. Healy in fiscal 2024, including a base salary of $254,683. Contineum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Contineum Therapeutics, Inc. includes Carmine N. Stengone (CEO and Board Member), Peter T. Slover (CFO), Diego Miralles (Board Member) and 6 others.

Affiliation history

Company network

Leadership on record at Contineum Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Contineum Therapeutics, Inc. (CTNM) $254,683 $2,562,489

Recent activity

No call appearances or filed executive changes recorded yet.